Uhlig K, Macleod A, Craig J, Lau J, Levey A S, Levin A, Moist L, Steinberg E, Walker R, Wanner C, Lameire N, Eknoyan G
Department of Medicine, Tufts New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02111, USA.
Kidney Int. 2006 Dec;70(12):2058-65. doi: 10.1038/sj.ki.5001875. Epub 2006 Sep 27.
Considerable variation in grading systems used to rate the strength of guideline recommendations and the quality of the supporting evidence in Nephrology highlights the need for a uniform, internationally accepted, rigorous system. In 2004, Kidney Disease: Improving Global Outcomes (KDIGO) commissioned a methods expert group to recommend an approach for grading in future nephrology guidelines. This position statement by KDIGO recommends adopting the Grades of Recommendation Assessment, Development, and Evaluation (GRADE) approach for the grading of evidence and guidelines on interventions. The GRADE approach appraises systematic reviews of the benefits and harms of an intervention to determine its net health benefit. The system considers the design, quality, and quantity of studies as well as the consistency and directness of findings when grading the quality of evidence. The strength of the recommendation builds on the quality of the evidence and additional considerations including costs. Adaptations of the GRADE approach are presented to address some issues pertinent to the field of nephrology, including (1) the need to extrapolate from studies performed predominantly in patients without kidney disease, and (2) the need to use qualitative summaries of effects when it is not feasible to quantitatively summarize them. Further refinement of the system will be required for grading of evidence on questions other than those related to intervention effects, such as diagnostic accuracy and prognosis.
用于评估肾脏病学指南建议强度和支持证据质量的分级系统存在很大差异,这凸显了需要一个统一的、国际认可的、严格的系统。2004年,改善全球肾脏病预后组织(KDIGO)委托一个方法专家组推荐未来肾脏病学指南的分级方法。KDIGO的这份立场声明建议采用推荐分级评估、制定和评价(GRADE)方法对干预措施的证据和指南进行分级。GRADE方法评估对一项干预措施的利弊进行的系统评价,以确定其净健康效益。该系统在对证据质量进行分级时会考虑研究的设计、质量和数量以及研究结果的一致性和直接性。推荐的强度基于证据的质量以及包括成本在内的其他考虑因素。文中介绍了对GRADE方法的调整,以解决与肾脏病学领域相关的一些问题,包括:(1)需要从主要在非肾脏病患者中进行的研究进行外推;(2)当无法对效应进行定量总结时,需要使用效应的定性总结。对于与干预效应无关的问题(如诊断准确性和预后)的证据分级,还需要对该系统进行进一步完善。